Pedro Santamaria
18Patents
7h-index
5Co-inventors
59Inventor score
Filing activity: Mar 6, 1991 → Nov 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8354110B2 | Compositions and methods for the prevention and treatment of autoimmune conditions | Physics | 29 | Active |
| US5578443A | DNA sequence-based HLA typing method | Chemistry; Metallurgy | 24 | Expired |
| US5424184A | DNA sequence-based HLA class I typing method | Chemistry; Metallurgy | 21 | Expired |
| US9511151B2 | Compositions and methods for the prevention and treatment of cancer | Human Necessities | 13 | Active |
| US5629149A | DNA sequence-based HLA typing method | Chemistry; Metallurgy | 12 | Expired |
| US5972604A | DNA sequence-based HLA typing method | Chemistry; Metallurgy | 10 | Expired |
| US10124045B2 | Methods and compositions for sustained immunotherapy | Emerging Cross-Sectional Technologies | 8 | Active |
| US10080808B2 | Methods and compositions for treating multiple sclerosis and related disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US10485882B2 | Nanoparticle compositions for sustained therapy | Human Necessities | 5 | Active |
| US10172955B2 | Compositions and methods for the prevention and treatment of cancer | Human Necessities | 5 | Active |
| US9603948B2 | Methods and compositions for treating multiple sclerosis and related disorders | Emerging Cross-Sectional Technologies | 4 | Active |
| US5593830A | DNA sequence-based HLA class I typing method | Chemistry; Metallurgy | 4 | Expired |
| US11000596B2 | Compositions and methods for the prevention and treatment of cancer | Human Necessities | 3 | Active |
| US10905773B2 | Methods and compositions for treating multiple sclerosis and related disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US10988516B2 | Methods and compositions for treating inflammation | Emerging Cross-Sectional Technologies | 2 | Active |
| US11338024B2 | Methods and compositions for sustained immunotherapy | Emerging Cross-Sectional Technologies | 2 | Active |
| US12011480B2 | Nanoparticle compositions for sustained therapy | Human Necessities | 1 | Active |
| US12397038B2 | Ubiquitous antigens for treatment of autoimmune or inflammatory diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.